Target intelligence / Profile preview

Gastrointestinal microbiota–host cell adhesion interface

Molecular classification
Other (interface/biological system rather than single molecule), Adhesion molecules (e.g., mucins, collagens), Bacterial surface adhesins (e.g., mucus-binding proteins, pili), Immune mediators
01

Overview

The gastrointestinal microbiota–host cell adhesion interface is formed by interactions between commensal and pathogenic bacteria and the surface molecules (mucins, collagens, immune factors) of host intestinal epithelial cells. This dynamic barrier controls colonization, immune tolerance, and exclusion of pathogens. Bacteria adhere to host cells via specialized adhesins—such as mucus-binding proteins and pili—which interact with mucins and other matrix proteins. Host cells regulate bacterial colonization by modifying glycosylation patterns in mucins and can respond through immune mechanisms involving secretory IgA, antimicrobial peptides, and cytokines. The integrity of this interface is crucial for maintaining gut homeostasis; its disruption is implicated in infectious, inflammatory, and metabolic diseases[1][2][3][4][5][6]. Note: This entry represents a biological concept rather than a discrete molecular target. For analytical, therapeutic, or bioinformatic use, it would be necessary to specify individual adhesion molecules (e.g., “Mucin MUC2” or “Collagen XV”) or microbial surface adhesins (e.g., “Mucus-binding protein Mub”) rather than use this broad interface term.

Other names
Gut microbiota–mucosal interfaceIntestinal microbiota–host adhesionMicrobial colonization sites
02

Mechanism of action

Modulation of microbial adhesion to host cells (by altering mucus composition or epithelial cell surface molecules); Changes in microbiota via competitive inhibition or enhancement of colonization resistance; Strengthening or weakening barrier function, thus influencing infection susceptibility

03

Biological functions

Barrier integrity maintenanceImmune modulationMicrobial colonizationRegulation of inflammationCompartmentalization of commensal and pathogenic microbesCompetitive exclusion of pathogens
04

Disease associations

Infection (bacterial/enteric)Inflammation (e.g., inflammatory bowel disease)Cancer (indirectly via chronic inflammation)Other (e.g., systemic immune disorders)
05

Safety considerations

Disruption can lead to dysbiosis, overgrowth of pathogens, and mucosal inflammationDifficulty in targeting without unintended alterations in beneficial microbiotaComplexity of ecological interactions: single interventions may have unpredictable systemic effects
06

Interacting drugs

Probiotics

3 more in the full profile.

07

Biomarkers

Levels or patterns of mucin glycosylationExpression levels of specific collagen isoforms (e.g., collagen II, XV)Quantities of attached commensal or pathogenic bacteriaShort-chain fatty acids (SCFA) and antimicrobial peptides in stool

Beyond the preview

Go deeper on Gastrointestinal microbiota–host cell adhesion interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal microbiota–host cell adhesion interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call